The Global Autoinjectors Market is expected to exhibit a CAGR of 25.2% over the forecast period from 2018 to 2023, according to a new report from Market Research Future (MRFR). Global Autoinjectors Research Report: By Type (Disposable Autoinjectors, Reusable Autoinjectors), by Therapy (Rheumatoid Arthritis, Diabetes, Others), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Others), End-User– Forecast Till 2023
The Global Autoinjectors Market is studied in detail in the report, including the key drivers and restraints affecting the market’s growth, the leading players operating in the global autoinjectors market, and the leading segments likely to dominate the global autoinjectors market over the forecast period.
Get Free Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6311
Autoinjectors are spring-loaded syringes designed for easy administration upon oneself or by an untrained person on the patient. The key intention behind the manufacturing of autoinjectors is to make the process of injecting the respective drug safer and easier to perform, so that untrained personnel can also do it in case of emergencies. The growing prevalence of chronic diseases such as diabetes and the growing preference among patients for home care solutions for the same is likely to be a major driver for the global autoinjectors market over the forecast period. Insulin injections for diabetes management have to be administered regularly, which may lead to the patient having to come into the hospital every time s/he needs an injection, which can be taxing for people living far away. Growing demand for home-based care and management when dealing with long-term diseases such as diabetes is likely to propel the global autoinjectors market over the forecast period.
The growing prevalence of allergies and subsequent cases of anaphylaxis is also likely to be a major driver for the global autoinjectors market, as autoinjectors are majorly used for injecting epinephrine in case of anaphylaxis.
Some of the key players in the global autoinjector market are
- AbbVie, Inc.,
- Eli Lily and Company,
- Amgen, Inc.,
- Dickinson and Company,
- Owen Mumford,
- Consort Medical,
- Unilife Corporation,
- SHL Group (Scandinavian Health Limited),
- Johnson & Johnson Services, Inc.,
- Teva Pharmaceutical Industries Ltd.,
- Antares Pharma,
- Novartis International AG, and
- Bayer AG.
Latest Industry News:
The FDA (Food & Drug Administration) has recently given approval for the first generic version of the EpiPen auto-injector.
AstraZeneca has received approval for its new autoinjector pen from the European Commission.
Aug 2018- The Food and Drug Administration has approved the first of its kind generic version of two epinephrine auto-injectors, EpiPen Jr and EpiPen. This will offer access to effective, safe and lower cost generic alternatives.
The global autoinjectors market has been segmented based on therapy, type, distribution channel, and region. by type, the market is divided between reusable autoinjectors and disposable autoinjectors. By therapy, the autoinjector market is segmented into diabetes, anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others. By distribution channel, the market includes hospital pharmacies, retail pharmacies, and others.
The regional segmentation of the global autoinjectors market divides it into Europe, the Americas, the Asia Pacific and the Middle East and Africa.
The Americas make up the most significant share of the global market and is followed closely by Europe which accounts for the second most significant region. A high prevalence of auto-immune conditions such as widespread allergies in these regions, combined with the availability of high-quality health care, a high number of leading market players and availability of research budgets act as crucial factors driving the growth of the autoinjectors market.
Meanwhile, the Asia Pacific is anticipated to grow at the highest CAGR during the forecast period due to the presence of a massive patient population and consistently growing economy. Emerging economies such as India are undergoing a transformation in healthcare with increasing investments being made in advancing the level of care offered in the region. A high diabetic population also spurs the demand for autoinjectors in the region.
Browse Complete Report visit https://www.marketresearchfuture.com/reports/autoinjectors-market-6311
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future
Hadapsar, Pune – 411028
Phone: +1 646 845 9312